SCHEMBL6424245

SCHEMBL6424245

Cc1c(C(C(=O)O)C2CCC2)c2c(F)c(O)ccc2n1C(=O)c1cccc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
HSD11B1 P28845 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
GRM5 P41594 6/20 0.36
IDO1 P14902 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
MGLL Q99685 1/20 0.35
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
SLC6A4 P31645 1/20 0.34
CHRNA3 P32297 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6425599 0.98 L3MBTL1 (0.39) ALDH1A1L3MBTL1HSD11B1KDM4ECNR1
SCHEMBL6423571 0.91 USP2 (0.39) ALDH1A1HSD11B1KDM4EGRM5MEN1
SCHEMBL6426725 0.89 ALDH1A1 (0.37) ALDH1A1L3MBTL1HSD11B1KDM4EGRM5
SCHEMBL6426581 0.89 TDP1 (0.41) ALDH1A1HSD11B1KDM4EMEN1KMT2A
SCHEMBL6425922 0.89 AKR1C3 (0.40) KDM4EMEN1KMT2AMGLLSLC6A3
SCHEMBL6426891 0.88 HSD11B1 (0.37) ALDH1A1HSD11B1SLC6A2SLC6A4SLC6A3
SCHEMBL6424426 0.88 KMT2A (0.36) ALDH1A1HSD11B1GRM5MEN1KMT2A
SCHEMBL6426945 0.88 PDE2A (0.35) HSD11B1MGLL
SCHEMBL6425475 0.88 L3MBTL1 (0.39) ALDH1A1L3MBTL1HSD11B1KDM4ECNR1
SCHEMBL6422936 0.87 AKR1C3 (0.40) ALDH1A1KDM4EMEN1KMT2AMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 ALDH1A1 630/4885L3MBTL1 4595/4885HSD11B1 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.